©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 114367
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114367
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114367
Table 3 India-specific risk stratification[4]
| Strong | Moderate | Mild | No effect | |
| Donor-related factors | Donor-recipient age matching | Older donor age | - | Deceased donor; ECD/cause of death/non-heart beating1; diabetes/hypertension, polycystic kidney disease; HCV status |
| Recipient-related factors | Donor-recipient age matching; HLA mismatch; presence of anti-HLA antibodies; presence of pre-transplant DSA and DSA titer | PRA | Re-transplantation | - |
| Transplant-related factors | Delayed graft function | - | Cold ischemia time | CMV/HIV/HCV infection1; gender; high BMI |
- Citation: Kute VB, Balwani MR, Shrimali JB, Pasari A, Kher V, Patel MP, Chafekar D, Guditi S, Das P, Siddaiah GM, Godara SM, Bhargava V, Gupta A, Ramteke V, Deshpande N, Tolani P, Prasad N, Patil RK, Mohanka R, Mahajan S, Sharma S, Banerjee S, Engineer DP, Agarwal D, Kashiv P, Lahiri A, Khullar D, Srivastava A. Induction therapy in kidney transplant recipients: A consensus statement of Indian Society of Organ Transplantation. World J Transplant 2026; 16(1): 114367
- URL: https://www.wjgnet.com/2220-3230/full/v16/i1/114367.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i1.114367